{"id":"W3171910277","doi":"10.1200/jco.2021.39.15_suppl.tps1101","title":"SERENA-4: A phase 3 comparison of AZD9833 (camizestrant) plus palbociclib, versus anastrozole plus palbociclib, for patients with ER-positive, HER2-negative advanced breast cancer who have not previously received systemic treatment for advanced disease.","year":2021,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Palbociclib; Medicine; Fulvestrant; Anastrozole; Oncology; Internal medicine; Breast cancer; Metastatic breast cancer; Cancer; Aromatase inhibitor; Estrogen receptor; Tamoxifen","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009530063,0.001571567,0.001213213,0.0006170266,0.0002672896,0.001004413,0.00107237,0.001263075,0.007275464],"category_scores_gemma":[0.0007418929,0.0005273847,0.001502109,0.0004182933,0.0006047293,0.0008530892,0.0002823173,0.003376483,0.001399078],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008648381,"about_ca_system_score_gemma":0.001116124,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001367446,"about_ca_topic_score_gemma":0.003837807,"domain_scores_codex":[0.9998187,0.00007742676,0.000009288681,0.0000331477,0.00002370144,0.0000376742],"domain_scores_gemma":[0.9997113,0.00005964483,0.0000653756,0.00001898468,0.00002045305,0.0001240682],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.7590408,0.04506527,0.002288057,0.001484597,0.001880456,0.0002185825,0.0002001269,0.003357367,0.04954145,0.0006228844,0.006876824,0.1294237],"study_design_scores_gemma":[0.6197358,0.3572501,0.007429262,0.000101116,0.000843372,0.0004353469,0.0001041223,0.002343589,0.005522723,0.0003792184,0.005809081,0.00004618231],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9759341,0.00932265,0.0009541165,0.001092823,0.0004435281,0.003341764,0.003020795,0.0003830166,0.005507156],"genre_scores_gemma":[0.9738606,0.007780722,0.002045705,0.001260768,0.0002252046,0.002344679,0.004913048,0.00005864737,0.00751064],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007275464,"threshold_uncertainty_score":0.02433884,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08469489683910919,"score_gpt":0.4701901440886904,"score_spread":0.3854952472495812,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}